» Articles » PMID: 37852668

Future Burden of Myocardial Infarction in Australia: Impact on Health Outcomes Between 2019 and 2038

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Myocardial infarction (MI) remains a major health burden in Australia. Yet the future burden of MI has not been extensively studied for the Australian population.

Methods And Results: A multistate lifetable model was constructed to estimate the lifetime risk of MI and project the health burden of MI for the Australian population aged between 40 and 100 years over a 20-year period (2019-2038). Data for the model were primarily sourced from the Victorian-linked dataset and supplemented with other national data. The lifetime risk of MI at age 40 was estimated as 24.4% for males and 13.2% for females in 2018. From 2019 to 2038, 891 142 Australians were projected to develop incident MI. By 2038, the model estimated there would be 702 226 people with prevalent MI, 51 262 incident non-fatal MI, and 3717 incident fatal MI; these numbers represent a significant increase compared to the 2019 estimates, with a 27.0% (148 827), 62.0% (19 629), and 104.7% (1901) rise, respectively. Projected years of life lived (YLL) (5% discount) accrued by the Australian population was 174 795 232 (84 356 304 in males and 90 438 928 in females), with 7 657 423 YLL among people with MI (4 997 009 in males and 2 660 414 in females).

Conclusion: The burden of MI was projected to increase between 2019 and 2038 in Australia. The outcomes of the model provide important information for decision-makers to prioritize population-wide prevention strategies to reduce the burden of MI.

Citing Articles

Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis.

Morton J, Liew D, Watts G, Zoungas S, Nicholls S, Reid C Pharmacoeconomics. 2024; 43(3):331-349.

PMID: 39617873 DOI: 10.1007/s40273-024-01454-z.


Impact of Smoking Reduction Scenarios on the Burden of Myocardial Infarction in the French Population Until 2035.

Kuhn J, Olie V, Grave C, Le Strat Y, Bonaldi C, Joly P Clin Epidemiol. 2024; 16:605-616.

PMID: 39262929 PMC: 11389704. DOI: 10.2147/CLEP.S440815.


Future Burden of Ischemic Stroke in Australia: Impact on Health Outcomes between 2019 and 2038.

Abebe T, Morton J, Ilomaki J, Ademi Z Neuroepidemiology. 2024; 58(6):449-459.

PMID: 38599203 PMC: 11633863. DOI: 10.1159/000538800.


Current and Future Cost Burden of Ischemic Stroke in Australia: Dynamic Model.

Abebe T, Ilomaki J, Livori A, Bell J, Morton J, Ademi Z Neuroepidemiology. 2024; 58(5):358-368.

PMID: 38560982 PMC: 11449186. DOI: 10.1159/000538564.

References
1.
Leening M, Ferket B, Steyerberg E, Kavousi M, Deckers J, Nieboer D . Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. 2014; 349:g5992. PMC: 4233917. DOI: 10.1136/bmj.g5992. View

2.
Bradshaw P, Alfonso H, Finn J, Owen J, Thompson P . A comparison of coronary heart disease event rates among urban Australian Aboriginal people and a matched non-Aboriginal population. J Epidemiol Community Health. 2010; 65(4):315-9. DOI: 10.1136/jech.2009.098343. View

3.
Marquina C, Talic S, Vargas-Torres S, Petrova M, Abushanab D, Owen A . Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029. Eur J Prev Cardiol. 2021; 29(8):1212-1219. DOI: 10.1093/eurjpc/zwab001. View

4.
Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D . Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018; 138(20):e618-e651. DOI: 10.1161/CIR.0000000000000617. View

5.
Wang Z, Hoy W . Lifetime risk of developing coronary heart disease in Aboriginal Australians: a cohort study. BMJ Open. 2013; 3(1). PMC: 3563122. DOI: 10.1136/bmjopen-2012-002308. View